Pergolide Mesilate May Improve Fatigue in Patients with Parkinson’s Disease
Objectives: Fatigue is a complaint frequently encountered among patients with Parkinson’s disease (PD). Considering the possible relationship between fatigue and dopaminergic dysfuncion, we investigated the effect of pergolide mesilate (a D2 and D1 dopamine receptor agonist) and bromocriptine (a D2...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2002-01-01
|
| Series: | Behavioural Neurology |
| Online Access: | http://dx.doi.org/10.1155/2002/473140 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832551913710682112 |
|---|---|
| author | Kazuo Abe Mayako Takanashi Takehiko Yanagihara Sabro Sakoda |
| author_facet | Kazuo Abe Mayako Takanashi Takehiko Yanagihara Sabro Sakoda |
| author_sort | Kazuo Abe |
| collection | DOAJ |
| description | Objectives: Fatigue is a complaint frequently encountered among patients with Parkinson’s disease (PD). Considering the possible relationship between fatigue and dopaminergic dysfuncion, we investigated the effect of pergolide mesilate (a D2 and D1 dopamine receptor agonist) and bromocriptine (a D2 selective dopamine receptor) in patients with PD. |
| format | Article |
| id | doaj-art-e35289b391b6409090b5bf8484580477 |
| institution | Kabale University |
| issn | 0953-4180 1875-8584 |
| language | English |
| publishDate | 2002-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Behavioural Neurology |
| spelling | doaj-art-e35289b391b6409090b5bf84845804772025-02-03T06:00:14ZengWileyBehavioural Neurology0953-41801875-85842002-01-01133-411712110.1155/2002/473140Pergolide Mesilate May Improve Fatigue in Patients with Parkinson’s DiseaseKazuo Abe0Mayako Takanashi1Takehiko Yanagihara2Sabro Sakoda3Department of Neurology, Osaka University Graduate School of Medicine, Osaka, JapanDepartment of Neurology, Osaka University Graduate School of Medicine, Osaka, JapanDepartment of Neurology, Osaka University Graduate School of Medicine, Osaka, JapanDepartment of Neurology, Osaka University Graduate School of Medicine, Osaka, JapanObjectives: Fatigue is a complaint frequently encountered among patients with Parkinson’s disease (PD). Considering the possible relationship between fatigue and dopaminergic dysfuncion, we investigated the effect of pergolide mesilate (a D2 and D1 dopamine receptor agonist) and bromocriptine (a D2 selective dopamine receptor) in patients with PD.http://dx.doi.org/10.1155/2002/473140 |
| spellingShingle | Kazuo Abe Mayako Takanashi Takehiko Yanagihara Sabro Sakoda Pergolide Mesilate May Improve Fatigue in Patients with Parkinson’s Disease Behavioural Neurology |
| title | Pergolide Mesilate May Improve Fatigue in Patients with Parkinson’s Disease |
| title_full | Pergolide Mesilate May Improve Fatigue in Patients with Parkinson’s Disease |
| title_fullStr | Pergolide Mesilate May Improve Fatigue in Patients with Parkinson’s Disease |
| title_full_unstemmed | Pergolide Mesilate May Improve Fatigue in Patients with Parkinson’s Disease |
| title_short | Pergolide Mesilate May Improve Fatigue in Patients with Parkinson’s Disease |
| title_sort | pergolide mesilate may improve fatigue in patients with parkinson s disease |
| url | http://dx.doi.org/10.1155/2002/473140 |
| work_keys_str_mv | AT kazuoabe pergolidemesilatemayimprovefatigueinpatientswithparkinsonsdisease AT mayakotakanashi pergolidemesilatemayimprovefatigueinpatientswithparkinsonsdisease AT takehikoyanagihara pergolidemesilatemayimprovefatigueinpatientswithparkinsonsdisease AT sabrosakoda pergolidemesilatemayimprovefatigueinpatientswithparkinsonsdisease |